Recombinant CLEC4C (Litifilimab Biosimilar) 抗体 (PE)
This Humanized 单克隆 antibody specifically detects CLEC4C (Litifilimab Biosimilar) in FACS. It exhibits reactivity toward 人.
产品编号 ABIN7867220
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Recombinant CLEC4C (Litifilimab Biosimilar) 抗体 (PE) (ABIN7867220)
抗原
CLEC4C (Litifilimab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Humanized
克隆类型
单克隆
标记
This CLEC4C (Litifilimab Biosimilar) antibody is conjugated to PE
应用范围
Flow Cytometry (FACS)
-
-
原理
- PE-conjugated Anti-CLEC4C (litifilimab biosimilar) mAb
-
亚型
- E239D, IgG1, M241L
-
-
anti-CLEC4C (Litifilimab Biosimilar) antibody
Research Grade 适用: 人 FACS, ELISA 宿主: Humanized Monoclonal unconjugated Recombinant Antibody
-
-
应用备注
- Flow Cyt 1:100
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- Liquid PBS with 0.05 % Proclin300, 1 % BSA
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C
-
储存方法
- Store at 2°C-8°C for 6 months
-
有效期
- 6 months
-
-
- CLEC4C (Litifilimab Biosimilar)
-
别名
- litifilimab biosimilar
-
物质类
- Biosimilar
-
背景
-
Synonyms: BDCA-2,CD303,BIIB 059, BIIB-059, BIIB059
Target Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
-
UniProt
- Q8WTT0
抗原
-
You are here:
